Biocryst Pharmaceuticals Inc (BCRX)
Deferred Revenue
$12.32M
Quarterly · Period ending: · USD
BCRX Deferred Revenue
Latest reported$12.32Mperiod ending
Latest reported$12.32Mperiod ending
BCRX Quarterly Deferred Revenue ($0.00 → $12.32M)
Quarterly deferred revenue
High-resolution chart · PNG
BCRX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 12,320,000 | |
| 5,409,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 522,000 | |
| 1,779,000 | |
| 1,200,000 | |
| 1,224,000 | |
| 1,554,000 | |
| 1,521,000 | |
| 1,471,000 | |
| 1,421,000 | |
| 602,000 | |
| 551,000 | |
| 405,000 | |
| 150,000 | |
| 432,000 | |
| 715,000 | |
| 1,067,000 | |
| 2,120,000 | |
| 221,000 | |
| 221,000 | |
| 221,000 | |
| 221,000 | |
| 200,000 | |
| 300,000 | |
| 7,300,000 | |
| 8,484,000 | |
| 8,686,000 | |
| 1,717,000 | |
| 1,869,000 | |
| 2,022,000 | |
| 2,282,000 | |
| 2,134,000 | |
| 2,163,000 | |
| 2,163,000 | |
| 2,118,000 | |
| 6,499,000 | |
| 7,023,000 | |
| 7,086,000 | |
| 1,481,000 | |
| 1,482,000 | |
| 1,473,000 | |
| 1,473,000 | |
| 1,539,000 | |
| 1,538,000 | |
| 1,536,000 | |
| 1,392,000 | |
| 1,308,000 | |
| 4,072,000 | |
| 2,400,000 | |
| 9,786,000 | |
| 3,370,000 | |
| 3,321,000 | |
| 2,549,000 | |
| 2,496,534 | |
| 2,497,000 | |
| 2,497,000 | |
| 2,497,000 | |
| 2,496,534 | |
| 2,562,000 | |
| 2,581,000 | |
| 2,587,000 | |
| 2,565,285 | |
| 4,345,000 | |
| 4,345,000 | |
| 4,756,000 | |
| 4,658,266 | |
| 4,680,000 | |
| 4,620,000 | |
| 3,161,000 | |
| 2,699,463 | |
| 2,699,000 | |
| 2,391,000 | |
| 2,162,000 | |
| 873,786 | |
| 0 | |
| 0 | |
| 0 | |
| 300,000,000 | |
| 0 | |
| 0 | |
| 300,000 | |
| 300,000,000 | |
| 0 | |
| 0 | |
| 300,000 | |
| 0 | |
| 0 | |
| 0 | |
| 300,000 | |
| 300,000,000 | |
| 0 |